Skip to content

Clinical trials

Completed Lymphoma, B-Cell, Marginal Zone trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell, Marginal Zone Status: Completed Country / region: Switzerland Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20053
20061
20101
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
International Extranodal Lymphoma Study Group (IELSG)3
German High-Grade Non-Hodgkin's Lymphoma Study Group1
Loxo Oncology, Inc.1
Prelude Therapeutics1
Swiss Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell, Marginal Zone10
Lymphoma, Mantle-Cell7
Leukemia, Lymphocytic, Chronic, B-Cell6
Lymphoma, Follicular6
Lymphoma, Large B-Cell, Diffuse6
Burkitt Lymphoma5
Lymphoma, Non-Hodgkin5
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Waldenstrom Macroglobulinemia5
Leukemia, Myeloid, Acute4

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.